Clinical Trial Update: Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating autologous PRP and PPP eye drops for ocular graft-versus-host disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Autologous PPP Eye Drops (platelet-poor plasma eye drops)
• Autologous PRP Eye Drops (platelet-rich plasma eye drops)

Snippet

Sponsor: Ladan Espandar | Conditions: Graft-versus-host Disease | Phase 1 | Status: WITHDRAWN